Arix Bioscience PLC
LSE:ARIX
Relative Value
The Relative Value of one ARIX stock under the Base Case scenario is 0.42 GBX. Compared to the current market price of 142 GBX, Arix Bioscience PLC is Overvalued by 100%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ARIX Competitors Multiples
Arix Bioscience PLC Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
UK |
Arix Bioscience PLC
LSE:ARIX
|
183.8m GBP | 2 387.1 | 12.3 | -14.2 | -13.7 | ||
US |
Blackstone Inc
NYSE:BX
|
144.7B USD | 14 | 67.2 | 29.2 | 29.5 | ||
US |
BlackRock Inc
NYSE:BLK
|
113.4B USD | 6.2 | 19.2 | 16 | 17.1 | ||
US |
KKR & Co Inc
NYSE:KKR
|
84.1B USD | 5.8 | 22.8 | 52 | 52 | ||
ZA |
N
|
Ninety One Ltd
JSE:NY1
|
70.9B Zac | 0 | 0 | 0 | 0 | |
CA |
Brookfield Corp
NYSE:BN
|
64.9B USD | 0.7 | 67.4 | 7.6 | 10.9 | ||
LU |
R
|
Reinet Investments SCA
JSE:RNI
|
60.9B Zac | 0 | 0 | 0 | 0 | |
US |
Bank of New York Mellon Corp
NYSE:BK
|
42.6B USD | 2.4 | 13.8 | 51.7 | 0 | ||
US |
Ameriprise Financial Inc
NYSE:AMP
|
42B USD | 2.5 | 13.4 | 16.9 | 16.9 | ||
US |
Ares Management Corp
NYSE:ARES
|
40.6B USD | 11.2 | 89.6 | 47.3 | 59.2 | ||
UK |
3i Group PLC
LSE:III
|
28.1B GBP | 5.9 | 6.3 | 6.5 | 6.5 |